These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 387584)

  • 41. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
    Tanaka F; Sawada K; Yonemoto RH
    Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukocyte adherence inhibition microtest for the detection of cell-mediated immunity to tumor in gastric cancer patients.
    Koyama S; Sakita T; Fukutomi H; Kawakita I; Tamura N
    Oncology; 1981; 38(1):13-7. PubMed ID: 7003459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 48. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antineoplasm immunity testing in health workers at the ORL department of the Postgraduate Medical Institute].
    Síbl O; Holán V; Bláha K; Suchánková A
    Cesk Otolaryngol; 1980 Oct; 29(5):288-91. PubMed ID: 6256089
    [No Abstract]   [Full Text] [Related]  

  • 50. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
    Rapaport FT; Lawrence HS
    Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A; Halliday WJ
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract]   [Full Text] [Related]  

  • 54. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of serum factors and cell washings on leukocyte adherence inhibition in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Gan; 1980 Apr; 71(2):165-72. PubMed ID: 7009300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immuno-diagnosis of ovarian cancer by the aid of cell-mediated immunologic techniques.
    Ueda K; Toyokawa M; Nakamori H; Sako H; Umesaki N; Nakade J; Lee T; Sugawa T
    Osaka City Med J; 1977; 23(1):73-84. PubMed ID: 345183
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigen.
    Thomson DM; Tataryn DN; Schwartz R; MacFarlane JK
    Eur J Cancer (1965); 1979 Sep; 15(9):1095-106. PubMed ID: 393516
    [No Abstract]   [Full Text] [Related]  

  • 60. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.